WallStreetZenWallStreetZen

NASDAQ: ZYXI
Zynex Inc Stock

$12.37-0.21 (-1.67%)
Updated Mar 28, 2024
ZYXI Price
$12.37
Fair Value Price
$13.96
Market Cap
$397.95M
52 Week Low
$6.88
52 Week High
$14.75
P/E
45.81x
P/B
8.63x
P/S
2.1x
PEG
139.51x
Dividend Yield
N/A
Revenue
$184.32M
Earnings
$9.73M
Gross Margin
79.2%
Operating Margin
7.42%
Profit Margin
5.3%
Debt to Equity
1.97
Operating Cash Flow
$18M
Beta
1.01
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ZYXI Overview

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Zen Score

–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZYXI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZYXI ($12.37) is undervalued by 11.36% relative to our estimate of its Fair Value price of $13.96 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ZYXI ($12.37) is not significantly undervalued (11.36%) relative to our estimate of its Fair Value price of $13.96 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ZYXI ($12.37) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more ZYXI due diligence checks available for Premium users.

Be the first to know about important ZYXI news, forecast changes, insider trades & much more!

ZYXI News

Valuation

ZYXI fair value

Fair Value of ZYXI stock based on Discounted Cash Flow (DCF)
Price
$12.37
Fair Value
$13.96
Undervalued by
11.36%
ZYXI ($12.37) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZYXI ($12.37) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZYXI ($12.37) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ZYXI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
45.81x
Industry
26.84x
Market
44.51x
ZYXI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ZYXI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ZYXI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.63x
Industry
150.19x
ZYXI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZYXI price to earnings growth (PEG)

For valuing profitable companies with growth potential
ZYXI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ZYXI's financial health

Profit margin

Revenue
$47.3M
Net Income
$1.2M
Profit Margin
2.6%
ZYXI's Earnings (EBIT) of $13.67M... subscribe to Premium to read more.
Interest Coverage Financials
ZYXI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$136.9M
Liabilities
$90.8M
Debt to equity
1.97
ZYXI's short-term assets ($87.86M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZYXI's short-term assets ($87.86M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZYXI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ZYXI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$6.2M
Investing
$9.4M
Financing
-$13.6M
ZYXI's operating cash flow ($17.76M)... subscribe to Premium to read more.
Debt Coverage Financials

ZYXI vs Medical Distribution Stocks

TickerMarket Cap1d %P/EP/B
ZYXI$397.95M-1.67%45.81x8.63x
EDAP$272.71M+3.52%-11.85x4.41x
AHG$26.50M+4.50%-4.83x5.07x
OMI$2.12B-0.86%-51.31x2.30x
PDCO$2.48B-0.50%13.55x2.55x

Zynex Stock FAQ

What is Zynex's quote symbol?

(NASDAQ: ZYXI) Zynex trades on the NASDAQ under the ticker symbol ZYXI. Zynex stock quotes can also be displayed as NASDAQ: ZYXI.

If you're new to stock investing, here's how to buy Zynex stock.

What is the 52 week high and low for Zynex (NASDAQ: ZYXI)?

(NASDAQ: ZYXI) Zynex's 52-week high was $14.75, and its 52-week low was $6.88. It is currently -16.14% from its 52-week high and 79.8% from its 52-week low.

How much is Zynex stock worth today?

(NASDAQ: ZYXI) Zynex currently has 32,170,182 outstanding shares. With Zynex stock trading at $12.37 per share, the total value of Zynex stock (market capitalization) is $397.95M.

Zynex stock was originally listed at a price of $2.56 in Feb 25, 2004. If you had invested in Zynex stock at $2.56, your return over the last 20 years would have been 382.45%, for an annualized return of 8.19% (not including any dividends or dividend reinvestments).

How much is Zynex's stock price per share?

(NASDAQ: ZYXI) Zynex stock price per share is $12.37 today (as of Mar 28, 2024).

What is Zynex's Market Cap?

(NASDAQ: ZYXI) Zynex's market cap is $397.95M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zynex's market cap is calculated by multiplying ZYXI's current stock price of $12.37 by ZYXI's total outstanding shares of 32,170,182.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.